Introspect is a subsidiary of ATAI that aims to use digital tools and biomarkers for (psychedelic) therapies.
Explore more company info with a Tree membership
📰 Weekly newsletter about the business of psychedelics
📈 Extended company information (analyst view, fundraising, revenue numbers)
🪄 Priority company page updates